Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Siemens Healthineers AG (SHL)
Price€39.00Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €23.38B | €22.36B | €21.68B | €21.71B | €18.00B | €14.46B | €14.52B | €13.43B | €13.80B | €13.55B | €12.94B |
| Gross profit | €9.03B | €8.47B | €7.71B | €8.14B | €6.95B | €5.58B | €5.80B | €5.47B | €5.76B | €5.47B | €5.07B |
| Gross margin | 38.63% | 37.87% | 35.56% | 37.47% | 38.63% | 38.59% | 39.92% | 40.72% | 41.77% | 40.36% | 39.19% |
| Research & development | — | €1.92B | €1.87B | €1.78B | €1.55B | — | — | — | — | — | — |
| Operating expenses | €5.88B | €5.66B | €5.58B | €5.21B | €4.38B | €3.60B | €3.50B | €3.51B | €3.47B | €3.35B | €3.11B |
| Operating income | €3.15B | €2.81B | €2.13B | €2.92B | €2.57B | €1.98B | €2.30B | €1.96B | €2.29B | €2.12B | €1.96B |
| Operating margin | 13.49% | 12.56% | 9.83% | 13.47% | 14.27% | 13.69% | 15.82% | 14.60% | 16.60% | 15.63% | 15.17% |
| EBITDA | — | €4.22B | €3.78B | €4.26B | €3.53B | — | — | — | — | — | — |
| EBITDA margin | — | 18.88% | 17.44% | 19.62% | 19.59% | — | — | — | — | — | — |
| Net income | €2.17B | €1.96B | €1.52B | €2.05B | €1.75B | €1.42B | €1.59B | €1.28B | €1.44B | €1.33B | €1.29B |
| Net profit margin | 9.27% | 8.76% | 7.03% | 9.46% | 9.70% | 9.84% | 10.92% | 9.56% | 10.47% | 9.80% | 9.99% |
| Basic EPSper basic share | €1.90 | €1.72 | €1.34 | €1.81 | €1.53 | €1.31 | €1.57 | €1.26 | €1.43 | €1.31 | €1.28 |
| Diluted EPSper diluted share | €1.91 | €1.73 | €1.34 | €1.81 | €1.57 | €1.40 | €1.57 | €1.26 | €1.43 | €1.31 | €1.28 |